Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Lee

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responsesHolbrook E Kohrt, Chen-Tsen Shu, Tor B Stuge, et al.
Cancer Immunology Research|February 20, 2026
Baseline tumor features and systemic immune dynamics underlying efficacy in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumabJian Ye, Chongkai Wang, Colt A Egelston, et al.
Plos Medicine|December 4, 2004
Diversity and recognition efficiency of T cell responses to cancerTor B Stuge, Susan P Holmes, Sahdev Saharan, et al.
The Journal of Infectious Diseases|December 17, 2020
Connecting the Dots: Translating the Vaginal Microbiome Into a DrugLaurel A Lagenaur, Anke Hemmerling, Charles Chiu, et al.
Nature Medicine|October 7, 2003
Ex vivo identification, isolation and analysis of tumor-cytolytic T cellsValerie Rubio, Tor B Stuge, Naileshni Singh, et al.
Journal of Translational Medicine|July 29, 2011
Cytotoxic T lymphocyte responses against melanocytes and melanomaGwendolen Y Chang, Holbrook E Kohrt, Tor B Stuge, et al.
International Journal of Molecular Sciences|March 3, 2021
Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry DataAndrei S Rodin, Grigoriy Gogoshin, Seth Hilliard, et al.
Scientific Reports|November 11, 2015
Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell deathDobrin Draganov, Sailesh Gopalakrishna-Pillai, Yun-Ru Chen, et al.
The Journal of Clinical Investigation|March 6, 2003
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cellsJeffrey J Molldrem, Peter P Lee, Shreya Kant, et al.
Cancer Research Communications|September 28, 2023
Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung MetastasesJian Ye, Weihua Guo, Chongkai Wang, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 8, 2005
Rapid assessment of recognition efficiency and functional capacity of antigen-specific T-cell responsesHolbrook E Kohrt, Chen-Tsen Shu, Tor B Stuge, et al.
Cancer Immunology Research|February 20, 2026
Baseline tumor features and systemic immune dynamics underlying efficacy in MSS metastatic colorectal cancer treated with regorafenib, ipilimumab, and nivolumabJian Ye, Chongkai Wang, Colt A Egelston, et al.
Plos Medicine|December 4, 2004
Diversity and recognition efficiency of T cell responses to cancerTor B Stuge, Susan P Holmes, Sahdev Saharan, et al.
The Journal of Infectious Diseases|December 17, 2020
Connecting the Dots: Translating the Vaginal Microbiome Into a DrugLaurel A Lagenaur, Anke Hemmerling, Charles Chiu, et al.
Nature Medicine|October 7, 2003
Ex vivo identification, isolation and analysis of tumor-cytolytic T cellsValerie Rubio, Tor B Stuge, Naileshni Singh, et al.
Journal of Translational Medicine|July 29, 2011
Cytotoxic T lymphocyte responses against melanocytes and melanomaGwendolen Y Chang, Holbrook E Kohrt, Tor B Stuge, et al.
International Journal of Molecular Sciences|March 3, 2021
Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry DataAndrei S Rodin, Grigoriy Gogoshin, Seth Hilliard, et al.
Scientific Reports|November 11, 2015
Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell deathDobrin Draganov, Sailesh Gopalakrishna-Pillai, Yun-Ru Chen, et al.
The Journal of Clinical Investigation|March 6, 2003
Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cellsJeffrey J Molldrem, Peter P Lee, Shreya Kant, et al.
Cancer Research Communications|September 28, 2023
Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung MetastasesJian Ye, Weihua Guo, Chongkai Wang, et al.
Pageof 13